ArticleCell death discovery2025

Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer.

Yen-Han Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.